Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Barbot, Mattia; Mazzeo, Pierluigi; Lazzara, Martina; Ceccato, Filippo; Scaroni, Carla

Barbot, Mattia; Mazzeo, Pierluigi; Lazzara, Martina; Ceccato, Filippo; Scaroni, Carla.

Affiliation

Barbot M; Endocrinology Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Mazzeo P; Endocrinology Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Lazzara M; Endocrinology Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Ceccato F; Endocrinology Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Scaroni C; Endocrinology Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.

Front Endocrinol (Lausanne) ; 13: 934675, 2022.

Article in En | MEDLINE | ID: mdl-35979433

Subject(s)

Adrenal Hyperplasia, Congenital; Cardiovascular Diseases; Metabolic Syndrome; Adrenal Hyperplasia, Congenital/complications; Adrenal Hyperplasia, Congenital/diagnosis; Adrenal Hyperplasia, Congenital/epidemiology; Adult; Cardiovascular Diseases/complications; Cardiovascular Diseases/etiology; Glucocorticoids/therapeutic use; Hormone Replacement Therapy; Humans; Infant, Newborn; Metabolic Syndrome/complications; Metabolic Syndrome/epidemiology

Key words

cardiovascular risk; congenital adrenal hyperplasia (CAH)21-alpha hydroxylase deficiency; diabetes mellitus; glucocorticoid therapy; metabolic syndrome; obesity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Adrenal Hyperplasia, Congenital / Metabolic Syndrome Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Humans / Newborn Language: En Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google